awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38896683-E5A6D7F8-EBDE-4FC2-90BD-CDF5CF444F2B
Q38896683-E5A6D7F8-EBDE-4FC2-90BD-CDF5CF444F2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38896683-E5A6D7F8-EBDE-4FC2-90BD-CDF5CF444F2B
New uses for brentuximab vedotin and novel antibody drug conjugates in lymphoma.
P2860
Q38896683-E5A6D7F8-EBDE-4FC2-90BD-CDF5CF444F2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38896683-E5A6D7F8-EBDE-4FC2-90BD-CDF5CF444F2B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a653a35d963fbe4ad4fd4dffef5ee6e4e81d094e
P2860
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t